Interest of the Cone Beam Scanner of Temporal Bones in the Analysis of Conductive Hearing Loss
Launched by UNIVERSITY HOSPITAL, STRASBOURG, FRANCE · Dec 7, 2023
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking into a new imaging technology called a cone beam scanner to see how well it can help doctors understand and diagnose conductive hearing loss, a common condition where sound has trouble traveling through the outer or middle ear. As people age, this type of hearing loss becomes more frequent. Currently, CT scans of the temporal bones (the bones near the ear) are the standard way to diagnose this condition, but the quality of these scans can vary based on the equipment used. The researchers want to find out if the cone beam scanner offers better or more useful images for diagnosing conductive hearing loss.
To participate in this trial, individuals must be at least 18 years old and have had either a CT scan or a cone beam scan related to their conductive hearing loss between January 1, 2018, and December 31, 2020. It's important that participants are willing to allow their previous scan data to be used for research. Those who do not wish to participate will be excluded. If you join the study, you can expect to help researchers understand the effectiveness of this new imaging technique, potentially improving diagnosis and treatment for future patients with hearing loss.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Major subject (≥18 years old)
- • Subject having performed a CT scan or a cone beam for pre- and post-operative conductive hearing loss between January 01, 2018 and December 31, 2020
- • Subject who has not expressed his opposition, after being informed, to the reuse of his data for the purposes of this research.
- Exclusion Criteria:
- • Subject who expressed their opposition to participating in the study
About University Hospital, Strasbourg, France
The University Hospital of Strasbourg, France, is a leading academic medical center renowned for its commitment to advancing healthcare through innovative clinical research and patient-centered care. As a prominent sponsor of clinical trials, the institution collaborates with a diverse range of healthcare professionals and research teams to explore cutting-edge therapies and treatment modalities. With state-of-the-art facilities and a multidisciplinary approach, the University Hospital of Strasbourg plays a pivotal role in translating scientific discoveries into effective clinical applications, contributing significantly to the advancement of medical knowledge and improved patient outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Strasbourg, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported